Press Release: Cancer Commons Opens Enrollment in its N-of-1 Clinical Study, Enabling Personalized Off-Guideline Treatments for Advanced Cancer Patients at Any U.S. Hospital
The study is open to patients with any advanced cancer at any cancer hospital in the United States. Patients participate with their own oncologist, with no travel to a trial site required.
